Patent: RE39941

✉ Email this page to a colleague

Summary for Patent: RE39941

Title:	Amelioration of Dupuytren\'s disease
Abstract:	The cords of Dupuytren\'s disease are injected with collagenase, the hand is immediately immobilized and maintained immobile for several hours. The cord becomes relaxed or ruptured, relieving the hand contracture of the disease.
Inventor(s):	Wegman; Thomas L. (N. Merrick, NY)
Assignee:	Advance Biofactures Corporation (Lynbrook, NY)
Application Number:	11/094,753
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE39941
Patent Claims:	see list of patent claims

Details for Patent RE39941

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	June 04, 1965	⤷ Sign Up	2039-02-26
Auxilium Pharmaceuticals, Inc.	XIAFLEX	collagenase clostridium histolyticum	For Injection	125338	February 02, 2010	⤷ Sign Up	2039-02-26
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent RE39941

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Australia	5966198	⤷ Sign Up
Australia	733208	⤷ Sign Up
Germany	19813748	⤷ Sign Up
Denmark	177324	⤷ Sign Up
Denmark	40398	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.